• Something wrong with this record ?

Lower Urinary Tract Symptoms in Adult Females after Feminizing Genitoplasty for Congenital Adrenal Hyperplasia

J. Trachta, I. Mushtaq, N. Petrasova, O. Hradsky, R. Skaba

. 2021 ; 205 (5) : 1483-1489. [pub] 20201221

Language English Country United States

Document type Journal Article

PURPOSE: We investigated quality of life, long-term lower urinary tract symptoms, sexual function and subjective attitudes toward surgery in adult women after feminizing genitoplasty for congenital adrenal hyperplasia. MATERIALS AND METHODS: We retrospectively reviewed the medical files of all patients with congenital adrenal hyperplasia who underwent feminizing genitoplasty from 1996 to 2018 in our tertiary center. Of those, patients older than 16 years of age were asked to answer 1 nonvalidated and 3 standardized and validated questionnaires evaluating their current mental well-being (WHO-5 Well-Being Index), lower urinary tract symptoms (ICIQ-FLUTS) and sexual function (GRISS). The anonymized answers of this cross-sectional study were compared to a control group of 50 healthy females. Student's t-test, Pearson's χ2 test, Fisher's exact test and Spearman's rank correlation coefficient were performed. A p-value less than 0.05 was considered significant. RESULTS: Out of 106 patients who underwent feminizing genitoplasty, 64 patients were included and 32 patients, aged 17 to 40 years (median 25.5 years), answered the questionnaires (50% response rate). The difference between congenital adrenal hyperplasia and control group mental well-being was not statistically significant (WHO-5 median score 60 and 64, respectively; p=0.82). We found no significant difference in the lower urinary tract symptoms subscales of filling, voiding or incontinence, nor in the overall lower urinary tract symptoms score (ICIQ-FLUTS overall median score 3.5 and 3, respectively; p=0.43). CONCLUSIONS: We found in our group no abnormal mental well-being or prevalence of long-term symptoms of lower urinary tract dysfunction in adult female patients with congenital adrenal hyperplasia following feminizing genitoplasty.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025803
003      
CZ-PrNML
005      
20211026133502.0
007      
ta
008      
211013s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/JU.0000000000001509 $2 doi
035    __
$a (PubMed)33347777
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Trachta, Jan $u Pediatric Surgery and Urology Department, Motol University Hospital, Charles University, Prague, The Czech Republic
245    10
$a Lower Urinary Tract Symptoms in Adult Females after Feminizing Genitoplasty for Congenital Adrenal Hyperplasia / $c J. Trachta, I. Mushtaq, N. Petrasova, O. Hradsky, R. Skaba
520    9_
$a PURPOSE: We investigated quality of life, long-term lower urinary tract symptoms, sexual function and subjective attitudes toward surgery in adult women after feminizing genitoplasty for congenital adrenal hyperplasia. MATERIALS AND METHODS: We retrospectively reviewed the medical files of all patients with congenital adrenal hyperplasia who underwent feminizing genitoplasty from 1996 to 2018 in our tertiary center. Of those, patients older than 16 years of age were asked to answer 1 nonvalidated and 3 standardized and validated questionnaires evaluating their current mental well-being (WHO-5 Well-Being Index), lower urinary tract symptoms (ICIQ-FLUTS) and sexual function (GRISS). The anonymized answers of this cross-sectional study were compared to a control group of 50 healthy females. Student's t-test, Pearson's χ2 test, Fisher's exact test and Spearman's rank correlation coefficient were performed. A p-value less than 0.05 was considered significant. RESULTS: Out of 106 patients who underwent feminizing genitoplasty, 64 patients were included and 32 patients, aged 17 to 40 years (median 25.5 years), answered the questionnaires (50% response rate). The difference between congenital adrenal hyperplasia and control group mental well-being was not statistically significant (WHO-5 median score 60 and 64, respectively; p=0.82). We found no significant difference in the lower urinary tract symptoms subscales of filling, voiding or incontinence, nor in the overall lower urinary tract symptoms score (ICIQ-FLUTS overall median score 3.5 and 3, respectively; p=0.43). CONCLUSIONS: We found in our group no abnormal mental well-being or prevalence of long-term symptoms of lower urinary tract dysfunction in adult female patients with congenital adrenal hyperplasia following feminizing genitoplasty.
650    _2
$a mladiství $7 D000293
650    _2
$a kongenitální adrenální hyperplazie $x chirurgie $7 D000312
650    _2
$a dospělí $7 D000328
650    _2
$a postoj ke zdraví $7 D001294
650    _2
$a průřezové studie $7 D003430
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a ženské pohlavní orgány $x chirurgie $7 D005836
650    _2
$a lidé $7 D006801
650    _2
$a symptomy dolních močových cest $x epidemiologie $7 D059411
650    _2
$a pooperační komplikace $x epidemiologie $7 D011183
650    _2
$a kvalita života $7 D011788
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a zpráva o sobě $7 D057566
650    12
$a operace změny pohlaví $x psychologie $7 D057830
650    _2
$a sexualita $x fyziologie $7 D019529
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Mushtaq, Imran $u Great Ormond Street Hospital for Children, London, United Kingdom
700    1_
$a Petrasova, Natalia $u Pediatric Surgery and Urology Department, Motol University Hospital, Charles University, Prague, The Czech Republic
700    1_
$a Hradsky, Ondrej $u Department of Pediatrics, Motol University Hospital, Charles University, Prague, The Czech Republic
700    1_
$a Skaba, Richard $u Pediatric Surgery and Urology Department, Motol University Hospital, Charles University, Prague, The Czech Republic
773    0_
$w MED00003040 $t The Journal of urology $x 1527-3792 $g Roč. 205, č. 5 (2021), s. 1483-1489
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33347777 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133508 $b ABA008
999    __
$a ok $b bmc $g 1714724 $s 1146310
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 205 $c 5 $d 1483-1489 $e 20201221 $i 1527-3792 $m The Journal of urology $n J Urol $x MED00003040
LZP    __
$a Pubmed-20211013

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...